Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria.

× No keyword cloud information.

11 in total

Review 1. Complement control protein factor H: the good, the bad, and the inadequate.

Authors: Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal: Mol Immunol Date: 2010-08 Impact factor: 4.407

Review 2. Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors: Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal: Blood Date: 2005-07-28 Impact factor: 22.113

3. Acetylcholinesterase inactivation in young and old human red blood cells.

Authors: F Herz
Journal: Blut Date: 1975-07

Review 4. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.

Authors: Amy E DeZern; Robert A Brodsky
Journal: Hematol Oncol Clin North Am Date: 2015-03-07 Impact factor: 3.722

5. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.

Authors: W F Rosse; G L Logue; J Adams; J H Crookston
Journal: J Clin Invest Date: 1974-01 Impact factor: 14.808

6. Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization.

Authors: Anita Hill; Russell P Rother; Louise Arnold; Richard Kelly; Matthew J Cullen; Stephen J Richards; Peter Hillmen
Journal: Haematologica Date: 2010-02-09 Impact factor: 9.941

The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria.

Review 1. Complement control protein factor H: the good, the bad, and the inadequate.

Review 2. Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

3. Acetylcholinesterase inactivation in young and old human red blood cells.

Review 4. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.

5. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.

6. Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization.

Review 7. When does a PNH clone have clinical significance?

Review 8. Discrimination between host and pathogens by the complement system.

9. Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes.

10. Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going.